- Home
- TCRX vs DHX Comparison
TCRX vs DHX Comparison
Compare TCRX & DHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- DHX
- Stock Information
- Founded
- TCRX 2018
- DHX 1991
- Country
- TCRX United States
- DHX United States
- Employees
- TCRX N/A
- DHX N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- DHX Business Services
- Sector
- TCRX Health Care
- DHX Consumer Discretionary
- Exchange
- TCRX Nasdaq
- DHX Nasdaq
- Market Cap
- TCRX 90.5M
- DHX 89.7M
- IPO Year
- TCRX 2021
- DHX 2007
- Fundamental
- Price
- TCRX $1.45
- DHX $2.15
- Analyst Decision
- TCRX Strong Buy
- DHX Strong Buy
- Analyst Count
- TCRX 6
- DHX 2
- Target Price
- TCRX $9.50
- DHX $5.25
- AVG Volume (30 Days)
- TCRX 774.8K
- DHX 144.8K
- Earning Date
- TCRX 05-06-2025
- DHX 05-07-2025
- Dividend Yield
- TCRX N/A
- DHX N/A
- EPS Growth
- TCRX N/A
- DHX N/A
- EPS
- TCRX N/A
- DHX N/A
- Revenue
- TCRX $4,421,000.00
- DHX $138,202,000.00
- Revenue This Year
- TCRX $68.86
- DHX N/A
- Revenue Next Year
- TCRX $14.01
- DHX $0.88
- P/E Ratio
- TCRX N/A
- DHX N/A
- Revenue Growth
- TCRX N/A
- DHX N/A
- 52 Week Low
- TCRX $1.02
- DHX $1.21
- 52 Week High
- TCRX $9.29
- DHX $3.32
- Technical
- Relative Strength Index (RSI)
- TCRX 49.42
- DHX 65.12
- Support Level
- TCRX $1.33
- DHX $1.98
- Resistance Level
- TCRX $1.49
- DHX $2.14
- Average True Range (ATR)
- TCRX 0.11
- DHX 0.16
- MACD
- TCRX 0.02
- DHX 0.03
- Stochastic Oscillator
- TCRX 69.12
- DHX 100.00
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About DHX DHI Group Inc.
DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.